$Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker$
QR Code

QR Code

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker

Kyung Jae Ryu,1 Seunghoon Kim,2 Mee Kum Kim,3 Hae Jung Paik,1 Dong Hyun Kim1 1Department of Ophthalmology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea; 2RudaCure Co., LTD, Incheon, Korea; 3Department of Ophthalmology, Seoul National University College of Medicine, Seoul...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ryu KJ, Kim S, Kim MK, Paik HJ, Kim DH
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	dry eye disease ocular surface inflammation tear mmp-9 positivity corticosteroid Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/ca31216df33c41b39e8b182d6b17ba52
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease
par: Kuzmanović Elabjer B, et autres
Publié: (2020)

Sex differences in the effect of aging on dry eye disease
par: Ahn JH, et autres
Publié: (2017)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
par: Pepose JS, et autres
Publié: (2019)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
par: Alanazi SA, et autres
Publié: (2019)

Progress in tear microdesiccate analysis by combining various transmitted-light microscope techniques
par: Traipe-Salas,Felipe, et autres
Publié: (2016)

Dynamics of tear fluid desiccation on a glass surface: a contribution to tear quality assessment
par: Traipe-Castro,Leonidas, et autres
Publié: (2014)

Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears
par: Epitropoulos AT, et autres
Publié: (2020)

Stimulating Tear Production: Spotlight on Neurostimulation
par: Yu MD, et autres
Publié: (2021)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
par: Miyake K, et autres
Publié: (2017)

An assessment of the ocular tear film in patients with thyroid disorders
par: Alanazi SA, et autres
Publié: (2019)

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution
par: Favuzza E, et autres
Publié: (2020)

Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations
par: Kaido M, et autres
Publié: (2017)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
par: Torkildsen G, et autres
Publié: (2017)

Patient-reported severity of dry eye and quality of life in diabetes
par: Yazdani-Ibn-Taz MK, et autres
Publié: (2019)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
par: White DE, et autres
Publié: (2020)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
par: Molina-Solana P, et autres
Publié: (2020)

Evaluation of Tear Film Urea Level as a Diagnostic Marker of Dry Eye Disease: A Pilot Study
par: Gurunadh Satyanarayana Velamakanni, et autres
Publié: (2021)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
par: Nasser L, et autres
Publié: (2018)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
par: Yeu E, et autres
Publié: (2020)

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
par: White DE, et autres
Publié: (2020)

Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study
par: Gatell-Tortajada J
Publié: (2016)

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
par: Silverstein S, et autres
Publié: (2020)

Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye
par: Sambursky R
Publié: (2016)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
par: Miyake H, et autres
Publié: (2016)

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
par: Fogagnolo P, et autres
Publié: (2020)

Tissue mRNA expression in rat of newly described matrix metalloproteinases
par: BERNAL,FABIÁN, et autres
Publié: (2005)

Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye
par: Alanazi SA, et autres
Publié: (2019)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
par: Aragona P, et autres
Publié: (2020)

Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
par: Ng A, et autres
Publié: (2018)

Investigating the potential benefits of a new artificial tear formulation combining two polymers
par: Simmons PA, et autres
Publié: (2017)

Tear protein analysis in presumed congenital alacrima
par: Yaginuma S, et autres
Publié: (2018)

Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?
par: Paulbuddhe V, et autres
Publié: (2021)

Possible association between subtypes of dry eye disease and seasonal variation
par: Ayaki M, et autres
Publié: (2017)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
par: McDonald MB, et autres
Publié: (2018)

Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose
par: Wallerstein A, et autres
Publié: (2018)

Efficacy of polyethylene glycol–propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease
par: Aguilar A, et autres
Publié: (2018)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
par: Groß D, et autres
Publié: (2017)

Prevalence of Dry Eye and its Subtypes in an Elderly Population with Cataracts in Indonesia
par: Noor NA, et autres
Publié: (2020)

Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease
par: Mateo Orobia AJ, et autres
Publié: (2018)

Assessment of tear-evaporation rate in thyroid-gland patients
par: Abusharaha A, et autres
Publié: (2019)